GlaucoMate

GlaucoMate Inc.

Glaucoma care
should start
before sight is lost.

We’re developing AI tools to help care teams find people who may need glaucoma evaluation and support the assessment of eye images.

Meet FIND & ACCESS
A focus on earlier glaucoma careWhy it matters

The reason we’re here

You can’t act on
what you don’t
know is there.

Glaucoma damages the optic nerve and often develops without noticeable symptoms. By the time someone notices a change in their sight, vision may already be permanently lost.

Earlier evaluation gives people a chance to receive care before more damage occurs.

1 in 2

people with glaucoma
don’t know they have it.

Often silent

Early glaucoma usually has no symptoms.

Irreversible loss

Treatment cannot restore vision already lost.

Source: National Eye Institute

FIND & ACCESS

Two tools.
A shared purpose.

Help more people reach the right care, with the clinician at every decision.

GlaucoMate FIND

Patient identification

Who needs a
closer look?

FIND is being developed to help care teams identify people who may be at risk for glaucoma and prioritize them for clinical review.

The goal is to reach patients who might otherwise remain outside routine eye care.

Designed to supportPatient review and timely referral
GlaucoMate ACCESS

Ocular image assessment

What can the
images tell us?

ACCESS is being developed to assess OCT scans and fundus photographs for structural signs associated with glaucoma.

Its purpose is to support clinicians as they review eye images and decide what evaluation is needed.

Designed to supportImage assessment and clinical review

FIND and ACCESS are in development. Neither replaces a comprehensive eye examination or a clinician’s diagnosis.

The intended care pathway

Technology helps.
People make the decisions.

A patient flag is the start of a conversation. An image assessment is one part of an examination. Each step leads back to the care team.

  1. 01

    FIND

    Identify

    Highlight people who may need a closer look at their glaucoma risk.

  2. 02

    Care team

    Connect

    Review the concern, contact the patient and arrange appropriate eye care.

  3. 03

    ACCESS

    Assess

    Support the review of OCT scans and fundus photographs.

  4. 04

    Clinician

    Decide

    Combine the examination and relevant tests to determine diagnosis and follow-up.

Our approach

A better way to
reach people.
A responsibility
to get it right.

GlaucoMate Inc. is a company focused on earlier glaucoma care. We’re building tools around the needs of patients and the professionals responsible for their care.

Useful in real practice

Our aim is to support existing care pathways and make the next step easier to act on.

Evidence before claims

Clinical evaluation is central to development. Performance and usefulness must be demonstrated in the settings where our tools will be used.

Clinical judgment stays central

Our tools are intended to support qualified professionals. Diagnosis and treatment decisions remain with the clinician.

Partners & programs

Part of NVIDIA
Inception.

GlaucoMate Inc. is a member of NVIDIA Inception, a program supporting startups as they develop their technology and grow.

About NVIDIA Inception

Program member

NVIDIAInception

GlaucoMate Inc.

Company milestones

Eyecelerator

Eyecelerator at AAO 2026

Selected as a semifinalist in the Winning Pitch Challenge.

About the challenge

Let’s talk

Help shape what
comes next in
glaucoma care.

We welcome conversations with healthcare organizations, industry collaborators and investors who share our focus on earlier glaucoma care.

Contact GlaucoMate